Management of Women With Superficial Dyspareunia
Launched by UNIVERSITÉ DE REIMS CHAMPAGNE-ARDENNE · Nov 15, 2023
Trial Information
Current as of November 14, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding and managing a condition called superficial dyspareunia, which refers to pain that some women experience during sexual intercourse. This type of pain can be quite distressing and affects a significant number of women, leading to both physical discomfort and emotional challenges. The goal of the study is to explore better ways to help women who have this condition, ensuring they receive the care and support they need.
To participate in this trial, women must be at least 18 years old and have experienced ongoing pain during vaginal penetration. This includes pain at the entrance of the vagina or during the initial stages of penetration with a partner, fingers, or sex toys. Unfortunately, younger women, those under legal care, or those who choose not to participate won't be eligible. The trial is not yet recruiting participants, but once it starts, women involved can expect to contribute to a better understanding of this issue, which could lead to improved treatments in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Aged 18 or over
- * Superficial dyspareunia, i.e.:
- • Having already had several painful vaginal penetrative sex
- • Having pain at the intromission (at the beginning of the vagina and at the level of the vulva) and/or at the beginning of penetration (by a penis, fingers, sextoys)
- • Having persistent and/or recurrent pain (appearing in a manner regular)
- • Agreeing to participate in the study
- Exclusion Criteria:
- • Minors
- • Protected by law (guardianship, curatorship, safeguarding of justice)
- • Refusing to participate in the study
About Université De Reims Champagne Ardenne
Université de Reims Champagne-Ardenne (URCA) is a distinguished higher education institution located in France, recognized for its commitment to advancing research and innovation in various fields, including health sciences. With a strong focus on interdisciplinary collaboration, URCA actively engages in clinical trials aimed at improving patient outcomes and contributing to medical knowledge. The university fosters a dynamic research environment, equipped with state-of-the-art facilities and a network of experienced professionals, ensuring the integrity and rigor of its clinical studies while prioritizing ethical standards and participant safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Reims, France
Reims, France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported